Healthcare101

  The global healthcare industry is witnessing rapid transformation, driven by increasing investments in healthcare infrastructure, rising chronic disease prevalence, and technological advancements in patient care. Among the critical components supporting modern healthcare delivery are medical gases and medical gas equipment, which play an indispensable role in respiratory therapy, anesthesia, emergency care, intensive care, diagnostics, and pharmaceutical manufacturing. According to the latest market research, the global Medical Gas and Equipment Market is projected to grow from USD 18.50 billion in 2026 to USD 24.62 billion by 2031 , registering a compound annual growth rate (CAGR) of 5.9% during the forecast period. The market continues to expand as healthcare providers worldwide prioritize reliable gas delivery systems, advanced monitoring technologies, and uninterrupted gas supply across hospitals, clinics, and home healthcare settings. Download PDF Brochure The Growing Impo...

 In today’s rapidly evolving healthcare landscape, the demand for highly skilled medical professionals has never been greater. Traditional training methods—relying heavily on textbooks, lectures, and limited hands-on experience—are no longer sufficient to meet the complexities of modern medicine. This is where medical simulation software is playing a transformative role, enabling immersive, risk-free, and highly effective training environments. The Medical Simulation Software market , valued at USD 0.18 billion in 2024, stood at USD 0.21 billion in 2025 and is projected to advance at a resilient CAGR of 16.7% from 2025 to 2030, culminating in a forecasted valuation of USD 0.46 billion by the end of the period. What is Medical Simulation Software? Medical simulation software refers to advanced digital platforms designed to replicate real-life clinical scenarios in a virtual or augmented environment. These tools allow healthcare professionals, students, and researchers to prac...

 The global healthcare industry is undergoing a major digital transformation, and nuclear medicine is at the center of this evolution. As hospitals and diagnostic centers increasingly adopt advanced imaging technologies and personalized treatment approaches, the demand for sophisticated nuclear medicine software solutions is accelerating rapidly. According to recent market estimates, the global Nuclear Medicine Software Market is projected to grow from USD 0.97 billion in 2025 to USD 1.49 billion by 2030, registering a CAGR of 9.0% during the forecast period. This growth is fueled by rising adoption of hybrid imaging systems, advancements in artificial intelligence (AI), expanding theranostics applications, and the increasing burden of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions. Understanding Nuclear Medicine Software Nuclear medicine software refers to specialized digital platforms used for processing, analyzing, managing, and int...

  According to MarketsandMarkets™, the Veterinary Orthopedics Market is projected to grow from about USD 0.57 billion in 2026 to USD 0.86 billion by 2031, at a CAGR of 8.5%. Browse through 766 market data tables and 59 figures spread across 624 pages and the in-depth TOC on the “Veterinary Orthopedics Market – Global Forecast to 2031” Veterinary Orthopedics Size & Forecast: Market Size Available for Years: 2025–2031 2026 Market Size: USD 0.57 billion 2031 Projected Market Size: USD 0.86 billion CAGR (2026–2031): 8.5% Veterinary Orthopedics Trends & Insights: The consumables segment is expected to register the highest CAGR of 10.2%. The metallic segment is expected to dominate the market with a share of 79.0% in 2025. The North American veterinary orthopedics market accounted for a share of 43.6% in 2025. Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=84026115  Advancements in veterinary orthopedics are largely driven by technological i...

  Radioligand therapy (RLT) is emerging as one of the most promising approaches in precision oncology, offering targeted treatment options for patients with difficult-to-treat cancers. According to recent market research, the global Radioligand Therapy (RLT) Market is projected to grow from USD 3.15 billion in 2025 to USD 10.91 billion by 2035 , registering a robust CAGR of 13.2% during the forecast period. The rapid expansion of the market reflects the growing importance of targeted radiopharmaceuticals in modern cancer care. Increasing cancer incidence, continuous innovation in radiolabeled therapeutics, expanding regulatory approvals, and strategic collaborations among pharmaceutical and biotechnology companies are collectively accelerating market growth. Download PDF Brochure Rising Demand for Precision Oncology Fuels Market Expansion Radioligand therapy combines the specificity of molecular targeting with the cancer-killing effects of radiation. By delivering radioactive ...